Budesonide
Revision as of 19:06, 15 November 2016 by Jonwarren (talk | contribs) (Created page with "==Administration== *Type: Inhaled corticosteroid *Dosage Forms: 3 DR *Routes of Administration: Inhaled *Common Trade Names: Pulmicort ==Adult Dosing== *1.5-2 mg NEB q 6...")
Administration
- Type: Inhaled corticosteroid
- Dosage Forms: 3 DR
- Routes of Administration: Inhaled
- Common Trade Names: Pulmicort
Adult Dosing
- 1.5-2 mg NEB q 6 hr
- Do not mix with other nebulized medications and rinse mouth after use
Pediatric Dosing
- Asthma maintenance
- 1-8 yo w/ prior bronchodilator alone
- 0.25-0.5 mg/day NEB divided qd-BID
- Start: 0.5 mg/day
- Max: 0.5 mg/day. Titrate to lowest effective dose.
- 0.25-0.5 mg/day NEB divided qd-BID
- 1-8 yo w/ prior inhaled steroid
- 0.25-1 mg/day NEB divided qd-BID
- Start: 0.5mg/day
- Max: 1 mg/day. Titrate to lowest effective dose.
- 0.25-1 mg/day NEB divided qd-BID
- 1-8 yo w/ prior oral steroid
- 0.25-1 mg/day NEB divided qd-BID
- Start: 1 mg/day
- Max: 1 mg/day. Titrate to lowest effective dose. Taper oral steroid gradually after >1 week.
- 0.25-1 mg/day NEB divided qd-BID
- 1-8 yo w/ prior bronchodilator alone
- Eosinophilic esophagitis
- <11 yo: 1 mg PO qd x4-12 weeks
- Mix 1 mg/2mL NEB w/ 5 g sucralose to form PO slurry.
- Avoid food/drink x30 min after each dose
- 11+ yo: 2 mg PO qd x4-12 weeks
- Mix 2 mg/4mL NEB w/ 10 g sucralose to form PO slurry.
- Avoid food/drink x30 min after each dose
- <11 yo: 1 mg PO qd x4-12 weeks
Special Populations
- Pregnancy Rating: B; drug of choice for pregnant pts w/ persistent asthma
- Lactation risk: L3; Safety unknown
Renal Dosing
- Adult: Not defined
- Pediatric: Not defined
Hepatic Dosing
- Adult: Not defined. Monitor closely with impairment.
- Pediatric: Not defined. Monitor closely with impairment.
Contraindications
- Allergy to class/drug
- Asthma, acute
- Status asthmaticus
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
